60 Degrees Pharmaceuticals, Inc.
SXTP
$0.97
-$0.01-0.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 71.68% | 20.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 71.68% | 20.13% | |||
| Cost of Revenue | 79.29% | -37.64% | |||
| Gross Profit | -215.19% | 103.52% | |||
| SG&A Expenses | -6.58% | -4.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.22% | -11.74% | |||
| Operating Income | -44.91% | 16.02% | |||
| Income Before Tax | -33.66% | 7.66% | |||
| Income Tax Expenses | -80.00% | 1,400.00% | |||
| Earnings from Continuing Operations | -33.55% | 7.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -41.67% | 50.00% | |||
| Net Income | -33.60% | 7.61% | |||
| EBIT | -44.91% | 16.02% | |||
| EBITDA | -45.26% | 16.31% | |||
| EPS Basic | 47.34% | 18.73% | |||
| Normalized Basic EPS | 46.40% | 19.58% | |||
| EPS Diluted | 47.34% | 18.73% | |||
| Normalized Diluted EPS | 46.40% | 19.58% | |||
| Average Basic Shares Outstanding | 149.53% | 14.76% | |||
| Average Diluted Shares Outstanding | 149.53% | 14.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||